Rafferty Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
|
|||||
|
2025
Q1 | $309K | Sell |
|
|||||
|
2024
Q4 | $359K | Sell |
|
|||||
|
2024
Q3 | $448K | Buy |
|
|||||
|
2024
Q2 | $395K | Sell |
|
|||||
|
2024
Q1 | $507K | Buy |
|
|||||
|
2023
Q4 | $403K | Buy |
|
|||||
|
2023
Q3 | $342K | Buy |
|
|||||
|
2023
Q2 | $300K | Buy |
|
|||||
|
2023
Q1 | $287K | Buy |
|
|||||
|
2022
Q4 | $280K | Buy |
|
|||||
|
2022
Q3 | $226K | Sell |
|
|||||
|
2022
Q2 | $246K | Sell |
|
|||||
|
2022
Q1 | $444K | Sell |
|
|||||
|
2021
Q4 | $914K | Buy |
|
|||||
|
2021
Q3 | $720K | Buy |
|
|||||
|
2021
Q2 | $460K | Buy |
|
|||||
|
2021
Q1 | $356K | Sell |
|
|||||
|
2020
Q4 | $571K | Buy |
|
|||||
|
2020
Q3 | $413K | Buy |
|